CooperVision Launches Avaira Toric Parameters with Plus Sphere Powers - New Options Expected to Further Strengthen Avaira Brand Momentum -
PLEASANTON, Calif., June 26, 2013 /PRNewswire/ -- In the midst of experiencing continued momentum for its Avaira® toric contact lenses, CooperVision Inc. (NYSE: COO) is launching additional parameters for the brand worldwide while expanding its market availability.
Beginning this June, the company will expand Avaira® toric lens parameters with new +0.25D to +6.00D sphere powers to correct for hyperopia. A 2011 study indicated that 15.7 percent of hyperopes were also astigmatic. 1
These new options join the existing parameter range, including sphere powers of plano to -6.00D in 0.25 steps; -6.50D to -10.00D in 0.50 steps; cylinder powers of -0.75, -1.25, and -1.75; and axes from 10 degrees to 180 degrees in 10 degree steps.
Approximately one-third of potential contact lens wearers require astigmatic correction. The newly expanded Avaira toric lens range now covers more than 90 percent of astigmats.1
"We're forecasting triple-digit percentage sales increases for Avaira toric lenses against our historic baseline, which we attribute to growing practitioner appreciation of excellent comfort benefits, outstanding visual acuity, and superior patient satisfaction ratings," said Dennis Murphy, executive vice president, Global Sales and Marketing, CooperVision. "With our ongoing investments in the brand to expand the parameters and availability, Avaira becomes an even stronger two-week toric lens option for practitioners around the world."
"Our practice has seen substantial increases in patient satisfaction when prescribing Avaira two-week toric lenses," said Dr. Jay Mashouf, Scripps Optometric Group. "Their combination of initial to end-of-wearing cycle comfort and visual acuity is difficult to match. Now, with plus powers, we have even more ways to meet and exceed the expectations of toric wearers."
A 2012 CooperVision study revealed that 8 out of 10 people who wear Avaira lenses do so for 14 hours or longer per day, making comfort an essential characteristic. The Avaira brand is the only two-week lens to have polyethylene glycol (PEG) bound at the lens surface and throughout the interior. This provides a distinct comfort advantage, not only at the end of each day, but during the entire wearing cycle. The benefit is due in part to the compound's well-established ability to tightly bind water, helping maintain hydration and eliminating the need for rewetting agents.
Avaira lenses with Aquaform® Comfort Science – in addition to their naturally wettable properties – also incorporate a high level of oxygen transmissibility (125 Dk/t sphere, 91 Dk/t toric), rounded edges that promote minimal lid interaction, and a smoother lens surface.
All Avaira toric lenses feature optimized lens geometry, uniform horizontal ISO thickness and wide ballast design, plus a larger toric optic zone. An ultraviolet radiation blocker helps protect wearers' eyes, limiting 75 percent of UVA and 99 percent of UVB rays.
For more information, please visit CooperVision.com/contact-lenses/avaira-toric
CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. The Company produces a full array of frequent replacement and daily disposable contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges; such as astigmatism and presbyopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, thereby creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 7,800 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
1 Young G, Sulley A, Hunt C. Prevalence of Astigmatism in Relation to Soft Contact Lens Fitting. Eye & Contact Lens 2011;37: 20–25.